Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentstorage vacuole

ARHGEF7 VAMP2

1.22e-044952GO:0000322
GeneOntologyCellularComponentpresynaptic active zone cytoplasmic component

UNC13B GUCY1B1 CTNNB1

1.51e-0423953GO:0098831
GeneOntologyCellularComponenttransferase complex

KANSL3 UBR1 UBR2 PRAMEF7 PHF20 PIK3C2A POLG RNF19B SPTLC1 DEPDC5 ARIH1 PRAMEF8 IKBKB

4.08e-049639513GO:1990234
GeneOntologyCellularComponentintracellular protein-containing complex

KANSL3 UBR1 UBR2 PRAMEF7 KIF23 AGO4 PHF20 POLG RNF19B DEPDC5 CTNNB1 ARIH1 PRAMEF8

4.46e-049729513GO:0140535
GeneOntologyCellularComponentmicrotubule associated complex

KIF23 KIF15 DNAH17 TRIM54 RP1

8.45e-04161955GO:0005875
GeneOntologyCellularComponentterminal bouton

UNC13B GRIP1 POLG GRIK5

9.66e-0496954GO:0043195
GeneOntologyCellularComponentNSL complex

KANSL3 PHF20

1.09e-0311952GO:0044545
GeneOntologyCellularComponentcell cortex region

UNC13B GUCY1B1 CTNNB1

1.12e-0345953GO:0099738
GeneOntologyCellularComponentubiquitin ligase complex

UBR1 UBR2 PRAMEF7 RNF19B DEPDC5 ARIH1 PRAMEF8

1.12e-03352957GO:0000151
GeneOntologyCellularComponentCul2-RING ubiquitin ligase complex

PRAMEF7 ARIH1 PRAMEF8

1.28e-0347953GO:0031462
GeneOntologyCellularComponentsynaptic membrane

UNC13B GRIP1 DLGAP1 IQSEC3 IL31RA KCND2 SYNE1 GRIK5 CTNNB1

1.34e-03583959GO:0097060
GeneOntologyCellularComponentcell cortex

UNC13B GRIP1 GUCY1B1 ARHGEF7 CTNNB1 FMNL1 EPB42

1.52e-03371957GO:0005938
DomainClpS_core

UBR1 UBR2

2.35e-052912IPR003769
DomainClpS

UBR1 UBR2

2.35e-052912PF02617
Domain-

UBR1 UBR2 BPTF PHF20 TRIM9 RNF19B VPS8 TRIM54 ARIH1 SP140

6.59e-0544991103.30.40.10
DomainRibosomal_L7/12_C/ClpS-like

UBR1 UBR2

7.02e-053912IPR014719
Domain-

UBR1 UBR2

7.02e-0539123.30.1390.10
DomainZnf_RING/FYVE/PHD

UBR1 UBR2 BPTF PHF20 TRIM9 RNF19B VPS8 TRIM54 ARIH1 SP140

7.91e-054599110IPR013083
DomainSynaptobrevin/VAMP

VAMP5 VAMP2

3.48e-046912IPR016444
DomainZF_UBR

UBR1 UBR2

4.85e-047912PS51157
Domainzf-UBR

UBR1 UBR2

4.85e-047912PF02207
DomainZnf_UBR

UBR1 UBR2

4.85e-047912IPR003126
DomainZnF_UBR1

UBR1 UBR2

4.85e-047912SM00396
DomainZF_RING_1

UBR1 UBR2 TRIM9 RNF19B VPS8 TRIM54 ARIH1

5.50e-04291917PS00518
DomainZF_RING_2

UBR1 UBR2 TRIM9 RNF19B VPS8 TRIM54 ARIH1

6.33e-04298917PS50089
DomainSYNAPTOBREVIN

VAMP5 VAMP2

6.45e-048912PS00417
Domain-

VAMP5 VAMP2

6.45e-0489121.10.3840.10
DomainMetalloPept_cat_dom

THOP1 MMEL1 ADAMTS20 ADAM29

6.59e-0481914IPR024079
Domain-

THOP1 MMEL1 ADAMTS20 ADAM29

6.59e-04819143.40.390.10
DomainE3_UB_ligase_RBR

RNF19B ARIH1

1.03e-0310912IPR031127
DomainZnf_RING

UBR1 UBR2 TRIM9 RNF19B VPS8 TRIM54 ARIH1

1.07e-03326917IPR001841
DomainSynaptobrevin

VAMP5 VAMP2

1.25e-0311912PF00957
DomainZINC_PROTEASE

THOP1 MMEL1 ADAMTS20 ADAM29

1.34e-0398914PS00142
DomainCOS_domain

TRIM9 TRIM54

1.50e-0312912IPR017903
DomainCOS

TRIM9 TRIM54

1.50e-0312912PS51262
DomainV_SNARE

VAMP5 VAMP2

1.50e-0312912PS50892
Pubmed

Toll-like receptors 2, 4, and 9 modulate promoting effect of COPD-like airway inflammation on K-ras-driven lung cancer through activation of the MyD88/NF-ĸB pathway in the airway epithelium.

MYD88 TLR4 IKBKB

6.86e-07795337283745
Pubmed

The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4.

MYD88 TLR4 IKBKB

1.09e-06895315029200
Pubmed

Stimulation of TLR4 Attenuates Alzheimer's Disease-Related Symptoms and Pathology in Tau-Transgenic Mice.

MYD88 TLR4 IKBKB

1.09e-06895327605009
Pubmed

A20 prevents inflammasome-dependent arthritis by inhibiting macrophage necroptosis through its ZnF7 ubiquitin-binding domain.

MYD88 TLR4 IKBKB

3.21e-061195331086261
Pubmed

Commensal-driven immune zonation of the liver promotes host defence.

MYD88 TLR4 CTNNB1

5.54e-061395333239787
Pubmed

Resistin competes with lipopolysaccharide for binding to toll-like receptor 4.

RETN TLR4

7.38e-06295219754671
Pubmed

MyD88-TLR4-dependent choroid plexus activation precedes perilesional inflammation and secondary brain edema in a mouse model of intracerebral hemorrhage.

MYD88 TLR4

7.38e-06295236482445
Pubmed

IL-4-dependent Th2 collateral priming to inhaled antigens independent of Toll-like receptor 4 and myeloid differentiation factor 88.

MYD88 TLR4

7.38e-06295215034070
Pubmed

Bound Waters Mediate Binding of Diverse Substrates to a Ubiquitin Ligase.

UBR1 UBR2

7.38e-06295228392261
Pubmed

Microglial activation by Citrobacter koseri is mediated by TLR4- and MyD88-dependent pathways.

MYD88 TLR4

7.38e-06295219812209
Pubmed

Ischemia-reperfusion lung injury is attenuated in MyD88-deficient mice.

MYD88 TLR4

7.38e-06295224146959
Pubmed

[Effect of yiqi huoxue recipe containing drug-serum on the Toll-Iike receptor-4 and its downstream signaling components MyD88 as well as the tumor necrosis factor receptor related factor-6 in human vein endothelial cells].

MYD88 TLR4

7.38e-06295220681284
Pubmed

Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway.

MYD88 TLR4

7.38e-06295219548630
Pubmed

Inhibitory Effects of the Lactobacillus rhamnosus GG Effector Protein HM0539 on Inflammatory Response Through the TLR4/MyD88/NF-кB Axis.

MYD88 TLR4

7.38e-06295233123130
Pubmed

Toll-like receptor 4 and myeloid differentiation factor 88 are required for gastric bypass-induced metabolic effects.

MYD88 TLR4

7.38e-06295234462225
Pubmed

Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction.

MYD88 TLR4

7.38e-06295218523439
Pubmed

DNAJC12 promotes lung cancer growth by regulating the activation of β‑catenin.

DNAJC12 CTNNB1

7.38e-06295233907820
Pubmed

Role of N-end rule ubiquitin ligases UBR1 and UBR2 in regulating the leucine-mTOR signaling pathway.

UBR1 UBR2

7.38e-06295220298436
Pubmed

Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis.

MYD88 TLR4

7.38e-06295225299052
Pubmed

Lys694Arg polymorphism leads to blunted responses to LPS by interfering TLR4 with recruitment of MyD88.

MYD88 TLR4

7.38e-06295232513051
Pubmed

TLR4 activation mediates kidney ischemia/reperfusion injury.

MYD88 TLR4

7.38e-06295217853945
Pubmed

TLR4-MyD88 pathway promotes the imbalanced activation of NLRP3/NLRP6 via caspase-8 stimulation after alkali burn injury.

MYD88 TLR4

7.38e-06295230008389
Pubmed

The acute exposure of tetrachloro-p-benzoquinone (a.k.a. chloranil) triggers inflammation and neurological dysfunction via Toll-like receptor 4 signaling: The protective role of melatonin preconditioning.

MYD88 TLR4

7.38e-06295228238930
Pubmed

Platycodin D inhibits MPP+-induced inflammatory response in BV-2 cells through the TLR4/MyD88/NF-κB signaling pathway.

MYD88 TLR4

7.38e-06295232429710
Pubmed

Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake.

MYD88 TLR4

7.38e-06295219461045
Pubmed

Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome).

UBR1 UBR2

7.38e-06295216311597
Pubmed

Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis.

TLR4 CTNNB1

7.38e-06295219786028
Pubmed

IKKβ is a β-catenin kinase that regulates mesenchymal stem cell differentiation.

CTNNB1 IKBKB

7.38e-06295229367460
Pubmed

Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand.

MYD88 TLR4

7.38e-06295218981086
Pubmed

Toll-like receptor 4-myeloid differentiation factor 88 signaling contributes to ventilator-induced lung injury in mice.

MYD88 TLR4

7.38e-06295220683250
Pubmed

The MyD88-independent pathway is not mobilized in human neutrophils stimulated via TLR4.

MYD88 TLR4

7.38e-06295217513785
Pubmed

Dioscin prevents LPS‑induced acute lung injury through inhibiting the TLR4/MyD88 signaling pathway via upregulation of HSP70.

MYD88 TLR4

7.38e-06295229512786
Pubmed

Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity.

MYD88 TLR4

7.38e-06295220381591
Pubmed

The protective effects of S14G-humanin (HNG) against lipopolysaccharide (LPS)- induced inflammatory response in human dental pulp cells (hDPCs) mediated by the TLR4/MyD88/NF-κB pathway.

MYD88 TLR4

7.38e-06295234605740
Pubmed

Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades.

MYD88 TLR4

7.38e-06295210607756
Pubmed

TLR-dependent phagosome tubulation in dendritic cells promotes phagosome cross-talk to optimize MHC-II antigen presentation.

MYD88 TLR4

7.38e-06295225313083
Pubmed

High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.

MYD88 TLR4

7.38e-06295220145615
Pubmed

The TLR4-MyD88 Signaling Axis Regulates Lung Monocyte Differentiation Pathways in Response to Streptococcus pneumoniae.

MYD88 TLR4

7.38e-06295233042124
Pubmed

Glabridin attenuates atopic dermatitis progression through downregulating the TLR4/MyD88/NF-κB signaling pathway.

MYD88 TLR4

7.38e-06295234021857
Pubmed

Expression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers.

MYD88 TLR4

7.38e-06295222985132
Pubmed

Nuclear factor translocation and acute anterior uveitis.

MYD88 TLR4

7.38e-06295221264236
Pubmed

The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol.

MYD88 TLR4

7.38e-06295211500829
Pubmed

The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.

MYD88 TLR4

7.38e-06295218792393
Pubmed

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.

MYD88 TLR4

7.38e-06295224977712
Pubmed

Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.

MYD88 TLR4

7.38e-06295215826931
Pubmed

Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation.

MYD88 TLR4

7.38e-06295222760779
Pubmed

Is serum amyloid A an endogenous TLR4 agonist?

MYD88 TLR4

7.38e-06295218252871
Pubmed

TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.

MYD88 TLR4

7.38e-06295219826413
Pubmed

Schistosome larvae stimulate macrophage cytokine production through TLR4-dependent and -independent pathways.

MYD88 TLR4

7.38e-06295216186163
Pubmed

Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice.

MYD88 TLR4

7.38e-06295211286707
Pubmed

Positive Correlation between Enhanced Expression of TLR4/MyD88/NF-κB with Insulin Resistance in Placentae of Gestational Diabetes Mellitus.

MYD88 TLR4

7.38e-06295227340831
Pubmed

Concomitant inhalation of cigarette smoke and aerosolized protein activates airway dendritic cells and induces allergic airway inflammation in a TLR-independent way.

MYD88 TLR4

7.38e-06295219635922
Pubmed

Lipopolysaccharide stimulation of trophoblasts induces corticotropin-releasing hormone expression through MyD88.

MYD88 TLR4

7.38e-06295218771998
Pubmed

Disruption of membrane cholesterol stimulates MyD88-dependent NF-kappaB activation in immature B cells.

MYD88 TLR4

7.38e-06295215331330
Pubmed

A Novel 1,8-Naphthyridine-2-Carboxamide Derivative Attenuates Inflammatory Responses and Cell Migration in LPS-Treated BV2 Cells via the Suppression of ROS Generation and TLR4/Myd88/NF-κB Signaling Pathway.

MYD88 TLR4

7.38e-06295233802409
Pubmed

Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse.

POLG TLR4

7.38e-06295222962610
Pubmed

Chlamydial heat shock protein 60 induces acute pulmonary inflammation in mice via the Toll-like receptor 4- and MyD88-dependent pathway.

MYD88 TLR4

7.38e-06295219398543
Pubmed

Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway.

MYD88 TLR4

7.38e-06295226655640
Pubmed

V gamma 4+ gamma delta T cells regulate airway hyperreactivity to methacholine in ovalbumin-sensitized and challenged mice.

MYD88 TLR4

7.38e-06295212960345
Pubmed

Toll-Like Receptor 4 Is an Essential Upstream Regulator of On-Time Parturition and Perinatal Viability in Mice.

MYD88 TLR4

7.38e-06295226151355
Pubmed

Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway.

MYD88 TLR4

7.38e-06295227452656
Pubmed

Adjuvant-mediated tumor regression and tumor-specific cytotoxic response are impaired in MyD88-deficient mice.

MYD88 TLR4

7.38e-06295214744795
Pubmed

Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.

MYD88 TLR4

7.38e-06295219494325
Pubmed

Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema.

MYD88 TLR4

7.38e-06295219376887
Pubmed

TLR4 Influences Hepatitis B Virus Related Hepatocellular Carcinoma by Regulating the Wnt/β-Catenin Pathway.

TLR4 CTNNB1

7.38e-06295228578348
Pubmed

Qing Hua Chang Yin exerts therapeutic effects against ulcerative colitis through the inhibition of the TLR4/NF-κB pathway.

MYD88 TLR4

7.38e-06295223900586
Pubmed

Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia.

PTPRG CTNNB1

7.38e-06295232225105
Pubmed

Opioid activation of toll-like receptor 4 contributes to drug reinforcement.

MYD88 TLR4

7.38e-06295222895704
Pubmed

HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma.

MYD88 TLR4

7.38e-06295229916535
Pubmed

Impaired neurogenesis and cardiovascular development in mice lacking the E3 ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway.

UBR1 UBR2

7.38e-06295216606826
Pubmed

Resistin inhibits neuronal autophagy through Toll-like receptor 4.

RETN TLR4

7.38e-06295229773580
Pubmed

Humoral immune response to flagellin requires T cells and activation of innate immunity.

MYD88 TLR4

7.38e-06295216920916
Pubmed

Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties.

RETN TLR4

7.38e-06295228991224
Pubmed

TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells.

MYD88 TLR4

7.38e-06295230066873
Pubmed

Maternal Neutrophil Depletion Fails to Avert Systemic Lipopolysaccharide-Induced Early Pregnancy Defects in Mice.

MYD88 TLR4

7.38e-06295234360700
Pubmed

Ursolic acid exhibits anti-inflammatory effects through blocking TLR4-MyD88 pathway mediated by autophagy.

MYD88 TLR4

7.38e-06295231302461
Pubmed

Low-intensity pulsed ultrasound (LIPUS) inhibits LPS-induced inflammatory responses of osteoblasts through TLR4-MyD88 dissociation.

MYD88 TLR4

7.38e-06295224091132
Pubmed

Human resistin protects against endotoxic shock by blocking LPS-TLR4 interaction.

RETN TLR4

7.38e-06295229133417
Pubmed

Methicillin-Resistant Staphylococcus Aureus infection exacerbates NSCLC cell metastasis by up-regulating TLR4/MyD88 pathway.

MYD88 TLR4

7.38e-06295227545207
Pubmed

Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia.

UBR1 UBR2

7.38e-06295215548684
Pubmed

MyD88 Signaling Accompanied by Microbiota Changes Supports Urinary Bladder Carcinogenesis.

MYD88 TLR4

7.38e-06295239000291
Pubmed

Aspirin-Triggered Lipoxin Protects Lipopolysaccharide-Induced Acute Kidney Injury via the TLR4/MyD88/NF-κB Pathway.

MYD88 TLR4

7.38e-06295233229758
Pubmed

Role of Bacillus anthracis spore structures in macrophage cytokine responses.

MYD88 TLR4

7.38e-06295217339355
Pubmed

Sepsis-induced organ failure is mediated by different pathways in the kidney and liver: acute renal failure is dependent on MyD88 but not renal cell apoptosis.

MYD88 TLR4

7.38e-06295216518342
Pubmed

Essential role for TLR4 and MyD88 in the development of chronic intestinal nematode infection.

MYD88 TLR4

7.38e-06295214579265
Pubmed

TLR4 activates the β-catenin pathway to cause intestinal neoplasia.

TLR4 CTNNB1

7.38e-06295223691015
Pubmed

Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in mice.

MYD88 TLR4

7.38e-06295221955045
Pubmed

The Toll-receptor family and control of innate immunity.

MYD88 TLR4

7.38e-06295210047546
Pubmed

B cell receptor cross-talk: exposure to lipopolysaccharide induces an alternate pathway for B cell receptor-induced ERK phosphorylation and NF-kappa B activation.

MYD88 TLR4

7.38e-06295217579042
Pubmed

Role of progesterone in TLR4-MyD88-dependent signaling pathway in pre-eclampsia.

MYD88 TLR4

7.38e-06295224142728
Pubmed

Kinesin family member 23 knockdown inhibits cell proliferation and epithelial-mesenchymal transition in esophageal carcinoma by inactivating the Wnt/β-catenin pathway.

KIF23 CTNNB1

7.38e-06295237162618
Pubmed

Anti-inflammatory effects of royal poinciana through inhibition of toll-like receptor 4 signaling pathway.

MYD88 TLR4

7.38e-06295226971223
Pubmed

Toll-like receptor 4 deficiency causes pulmonary emphysema.

MYD88 TLR4

7.38e-06295217053835
Pubmed

Prognostic value of myeloid differentiation primary response 88 and Toll-like receptor 4 in breast cancer patients.

MYD88 TLR4

7.38e-06295225360699
Pubmed

Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: role of the innate immune response in Celiac disease.

MYD88 TLR4

7.38e-06295216456012
Pubmed

Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.

MYD88 TLR4

7.38e-06295222537289
Pubmed

Structural basis of substrate recognition and specificity in the N-end rule pathway.

UBR1 UBR2

7.38e-06295220835242
Pubmed

Immune activated monocyte exosomes alter microRNAs in brain endothelial cells and initiate an inflammatory response through the TLR4/MyD88 pathway.

MYD88 TLR4

7.38e-06295228855621
Pubmed

Toll-Like Receptor 4-Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model.

MYD88 TLR4

7.38e-06295228446897
Pubmed

Drosophila MyD88 is required for the response to fungal and Gram-positive bacterial infections.

MYD88 TLR4

7.38e-06295211743586
InteractionCROCC interactions

UBR1 UBR2 SYNE1 CEP250 CTNNB1

7.32e-0659925int:CROCC
GeneFamilyUbiquitin protein ligase E3 component n-recognins

UBR1 UBR2

2.56e-047642785
GeneFamilyVesicle associated membrane proteins

VAMP5 VAMP2

2.56e-04764212
CoexpressionMCCLUNG_COCAINE_REWARD_5D

KIF23 KRT16 KCND2 VAMP2 FMNL1

7.94e-0675955MM658
CoexpressionMCCLUNG_COCAINE_REWARD_5D

KIF23 KRT16 KCND2 VAMP2 FMNL1

7.94e-0675955M1539
ToppCellControl-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations)

UNC13B DLGAP1 PTPRG NECAB1 SYNE1 CFAP221

2.44e-06180956198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PTPRG CFAP221 DNAH17 RP1 PLEKHD1 BICD1

3.33e-061909561cf023e3c6924d6a06f353d4b62444b6f2fee8a7
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PTPRG CFAP221 DNAH17 RP1 PLEKHD1 BICD1

3.33e-0619095659bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCellPosterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb-Excitatory_Neuron.Sc17a7.Rorb-Gpr83_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

MMEL1 CFAP221 TKTL2 C4orf54 MYBPC3

3.54e-061089555af010a1ee6535b144ccd16999c225508a4b3433
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

KIF23 ATP11B TRIM9 HMGCS1 RP1

2.46e-051619554bb7bae54ba3bdf46b525c01f5ad3db8e49819cb
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRANK1 OTOGL SPTLC1 MYH15 RP1

3.11e-0516995512bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCellHealthy-RBC|Healthy / disease group, cell group and cell class

KIF23 KIF15 SLFN14 TKTL2 EPB42

3.87e-05177955945d72ab52efa9a9468daace9f9ec676a891d963
ToppCellGlobus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

GRIP1 IQSEC3 MMEL1 TCF25 PLEKHD1

4.42e-0518295504ccfa951eaa31fed6d140edb6c702d49363c5fa
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP1 PTPRG SYNE1 CFAP221 RP1

4.91e-05186955f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCellpdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

PIK3C2A SLC6A16 CFAP221 APLF BICD1

5.03e-051879557e376831a11ee72ed87abcdac631ca46ae29c250
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PTPRG CFAP221 DNAH17 RP1 BICD1

5.03e-05187955c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor

UNC13B PTPRG NECAB1 CFAP221 HMGCS1

5.70e-0519295506013a07e3a873b1d1c0451643c528593ac32a9c
ToppCellfacs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

LRRC8C UBR2 PTPRG SYNE1 CTNNB1

5.70e-051929551ccc47792edf9ee23501c8e2165d11271636b66a
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

UNC13B PTPRG NECAB1 SYNE1 CFAP221

5.84e-05193955fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

UNC13B NECAB1 SYNE1 CFAP221 RP1

5.84e-05193955bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

UNC13B PTPRG NECAB1 SYNE1 CFAP221

5.84e-05193955f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

UNC13B PTPRG NECAB1 SYNE1 PACSIN2

5.99e-0519495597534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCellCOVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations)

KIF23 KIF15 CCDC73 APOLD1 EPB42

6.14e-05195955764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCellCV-Moderate-6|CV / Virus stimulation, Condition and Cluster

BPTF PHF20 VAMP2 ARIH1 FMNL1

6.29e-051969557bced0cc2112697593c478fa291b8ed3941fb811
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

UNC13B NECAB1 SYNE1 HMGCS1 ARIH1

6.44e-05197955bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCellBronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

UNC13B PTPRG NECAB1 CFAP221 HMGCS1

6.60e-05198955f948391296c261c473d339069a6d0f20ccd6f38f
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GRIP1 DLGAP1 KCND2 STRBP SYNE1

6.60e-051989554ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PTPRG PIK3C2A VAMP5 SYNE1 TLR4

6.75e-051999555d976d57872a8a25a11fe8cd53b01aa21a1a519a
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

UNC13B PTPRG NECAB1 SYNE1 HMGCS1

6.75e-051999552dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

APOLD1 PIK3C2A VAMP5 SYNE1 TLR4

6.75e-0519995514e09eaa2335d4503de50250eb4258dd5b85b304
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

BPTF TUT4 AGO4 PTPRG PIK3C2A

6.92e-05200955dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellLPS_only-Hematopoietic_Erythro-Megakary|LPS_only / Treatment groups by lineage, cell group, cell type

KIF23 ATP11B KIF15 SLFN14 EPB42

6.92e-05200955ce8281c9556a1f64f8ca8a029110077d4ef5b35e
ToppCellkidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

APOLD1 PIK3C2A VAMP5 SYNE1 TLR4

6.92e-052009553007583eaad3a5ae2df010513d3e4df59155123d
ToppCellLPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_only / Treatment groups by lineage, cell group, cell type

KIF23 ATP11B KIF15 SLFN14 EPB42

6.92e-0520095583c4181c083b364f0d3a89ae7a0504781fa9fa9f
ToppCellLPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_only / Treatment groups by lineage, cell group, cell type

KIF23 ATP11B KIF15 SLFN14 EPB42

6.92e-05200955f15baf287ec467664c23faa53fdea45257f7b9d0
DrugCPG-oligonucleotide

MYD88 TRANK1 POLG POLH TLR4 ATXN3 INTS3 JMY

9.62e-07184948ctd:C408982
Diseasecerebellar ataxia (is_implicated_in)

SYNE1 POLG

9.77e-055932DOID:0050753 (is_implicated_in)
Diseaseunipolar depression, bipolar disorder

CCDC73 SYNE1 TLR4 MYH15 GRIK5

1.38e-04156935EFO_0003761, MONDO_0004985
DiseaseEosinophilia, Tropical

MYD88 TLR4

2.04e-047932C0014458
DiseaseEosinophilia

MYD88 TLR4

2.72e-048932C0014457
DiseaseSudden Cardiac Arrest

KCND2 MYBPC3

2.72e-048932C1720824
DiseasePneumonia

MYD88 TLR4 IKBKB

6.69e-0454933C0032285
DiseaseLobar Pneumonia

MYD88 TLR4 IKBKB

6.69e-0454933C0032300
DiseasePneumonitis

MYD88 TLR4 IKBKB

6.69e-0454933C3714636
DiseaseExperimental Lung Inflammation

MYD88 TLR4 IKBKB

6.69e-0454933C0887898
Diseaseeosinophil percentage of granulocytes

KANSL3 UBR2 BPTF CYP21A2 SP140

8.86e-04234935EFO_0007996
Disease1-Methylhistidine measurement

KCND2 OTOGL

1.30e-0317932EFO_0021543
Diseasecolorectal cancer, inflammatory bowel disease

GRIK5 SP140

1.62e-0319932EFO_0003767, MONDO_0005575
Diseasehepatitis B (is_marker_for)

MYD88 CTNNB1

1.98e-0321932DOID:2043 (is_marker_for)
Diseasetriacylglycerol 58:9 measurement

APOLD1 CYP21A2

2.18e-0322932EFO_0010443
Diseasehypertrophic cardiomyopathy (is_implicated_in)

RETN MYBPC3

2.18e-0322932DOID:11984 (is_implicated_in)
Diseasehepatocellular carcinoma (is_implicated_in)

MYD88 POLG TLR4 CTNNB1

2.61e-03181934DOID:684 (is_implicated_in)
Diseaseplatelet component distribution width

TRANK1 VAMP5 SYNE1 CYP21A2 SLFN14 C4orf54 JMY PACSIN2

2.67e-03755938EFO_0007984
Diseasecoronary artery calcification

KCND2 TRIM9 ATXN3 ADAM29 ARL9 GRIK5

3.04e-03450936EFO_0004723
Diseaseanogenital venereal wart (is_marker_for)

MYD88 TLR4

3.04e-0326932DOID:11168 (is_marker_for)

Protein segments in the cluster

PeptideGeneStartEntry
DFEEVQRCTADMNIT

PTPRG

851

P23470
QAQVDEVVDIMRVNV

VAMP2

36

P63027
ITCRMEFEEIDNSTQ

ADAM29

171

Q9UKF5
LQRLTVEVDCNMFQN

EPB42

661

P16452
EVEMQCTLRNSQVLD

APLF

106

Q8IW19
RCDEYVTQLDEMQRQ

BICD1

751

Q96G01
VCINTEDSQMEFLEI

ARL9

56

Q6T311
TTKMENEECNEQRER

DNAJC12

121

Q9UKB3
VSEMEVNGQFESVCE

DLGAP1

451

O14490
EICSFQQMLVQSLEE

ARHGEF7

321

Q14155
IEFMCEVLDIQNINE

AGO4

221

Q9HCK5
AEREENQRMIVCNQV

BPTF

2686

Q12830
MECTDNQIRQVNEIV

ADAMTS20

1556

P59510
DREDINSLCMTVVQN

HMGCS1

61

Q01581
NVEEMFNCITELVLR

RAB35

156

Q15286
DTEAQCEVMQEIVDQ

INTS3

591

Q68E01
VREFVMQEAQQNDDV

PPP4R3A

396

Q6IN85
QHMVECIREVNEVIQ

ARIH1

111

Q9Y4X5
VQEIAATCQDQMREI

APOLD1

151

Q96LR9
EETQQVLMEERNVFC

FBXW10B

386

O95170
IAMVCQERSQNETYE

OVOS1

61

Q6IE37
VQMTAQQVFEEFICQ

DEPDC5

791

O75140
MAAVVRCQEQAQTTD

PLA2G12A

16

Q9BZM1
TQQQFVEGVRMEEIV

CTNNB1

556

P35222
DLMNQIQELRTSVCE

KIF15

986

Q9NS87
EMTEQEIDTLCYQLQ

JMY

276

Q8N9B5
EMEQAVELCGRENEV

IKBKB

516

O14920
FQCIEVMQACVAEDQ

IL31RA

326

Q8NI17
EEEECNDHIQRMNFV

HORMAD2

266

Q8N7B1
DCEADQLLQMIRVQQ

ATXN3

171

P54252
EPVVEQLTQEFCERM

CYP21A2

136

P08686
QNNLIETMQRDVFCD

OPTC

276

Q9UBM4
LQEVEVQNEEMAAFC

PIK3C2A

371

O00443
EEEFQQDVMARACLQ

POLG

536

P54098
SVEEQLAQLRCEMEQ

KRT16

381

P08779
EQVFEESCMEVATVN

KCND2

496

Q9NZV8
DIQFVQEMIRQLEQT

MYD88

171

Q99836
VDIIENQVMDFRTQL

GSTM3

101

P21266
EIDMKVIQQRNEECD

GUCY1B1

161

Q02153
RDSCLVQEDMVQVLE

MMEL1

296

Q495T6
QFNRDVLDCVVDEMD

IQSEC3

711

Q9UPP2
MEQVFEQCQQFEEKR

PACSIN2

226

Q9UNF0
VILQEFCNQIIEMTR

DNAH17

336

Q9UFH2
VNQISLDECMEQRQE

DHX57

236

Q6P158
NTEQEIREENMENFC

CCDC73

421

Q6ZRK6
QLEEENQSVCSRMEA

CEP250

621

Q9BV73
EEERTQAESALCQMQ

CEP250

906

Q9BV73
LELTQREFVRQDDCM

FMNL1

926

O95466
LTQSMVDRCIQDEIV

KANSL3

451

Q9P2N6
SEEVSVCQEMLQELR

GRIK5

836

Q16478
MEDAVQILQQCEDLV

GRIP1

636

Q9Y3R0
MVITCQAVVNQREDS

C4orf54

1151

D6RIA3
VLNMVELDCIQEVEV

PRAMEF8

196

Q5VWM4
REDQFMIQVRQEEPC

OTOGL

1986

Q3ZCN5
MERQNQSCVVEFILL

OR10A6

1

Q8NH74
EENLQVMRFAEVTQE

KIF23

421

Q02241
ICEVQEENDFMIQCE

PHF20

656

Q9BVI0
EEINIQMTDQVAETC

RP1

406

P56715
VERELCEQNVEVMLT

CFAP221

771

Q4G0U5
ERIQPEDMFVCDINE

APIP

66

Q96GX9
DRECNNMEIQVDIEA

RNF19B

581

Q6ZMZ0
QVLNRCIQEEEDMRI

SLFN14

171

P0C7P3
MVLREVTECNIETQF

SLC6A16

456

Q9GZN6
VTECESRMVQSIDFQ

SYNE1

4876

Q8NF91
VARMQKEAEEVVQEC

MYH15

1746

Q9Y2K3
TRMVTQINCEFEEVV

SHOC1

26

Q5VXU9
EELEAVQNMVSTVEC

STRBP

26

Q96SI9
VEDTMVETIALCQRN

VPS8

1116

Q8N3P4
LVDMDCFFVQVEQRQ

POLH

11

Q9Y253
EQDVRLLQEIVDQCM

SPTLC1

406

O15269
EQVKSFLENMEVECN

COA7

11

Q96BR5
TLTENEMQFRECSIN

ATP11B

411

Q9Y2G3
VLNMVELDCIQEVEV

PRAMEF7

196

Q5VXH5
REQVEVDAQQCMLEI

nan

41

A6NIZ1
DRVQAVITQMEEVCQ

TRIM54

186

Q9BYV2
VITQMEEVCQTIEDN

TRIM54

191

Q9BYV2
TIMLRDSVIQECVQF

TTC30B

601

Q8N4P2
FEEVVQELRMEQEQI

PLEKHD1

201

A6NEE1
ERFIECIIAEQNMVS

TKTL2

361

Q9H0I9
QESDQCVMEVSDRRN

TFF2

76

Q03403
CQEEQEVKIENNAMV

UBR1

1101

Q8IWV7
CIIEEIARSQETNQM

UBR1

1726

Q8IWV7
CERMSEQIFTNVTQV

TANGO6

651

Q9C0B7
LERCQQQANEVTEIM

VAMP5

6

O95183
RQTMAEVFEKEQSIC

SEC63

476

Q9UGP8
FQVRIDECVRQMADI

UNC13B

1226

O14795
MVQQIQENSVEFEAC

TRIM9

301

Q9C026
QESEVLERQMCPEEQ

SP140

746

Q13342
DCLMQDITVLIQQVE

TRANK1

686

O15050
CSLVIRDAQMQDESQ

SIGLEC10

101

Q96LC7
MNQVEETRYCVDQNL

THOP1

341

P52888
INAEREQPVQCDEMD

TUT4

756

Q5TAX3
CQEEQEVKVESRAMV

UBR2

1111

Q8IWV8
LCSMEEAINERIQEV

RETN

21

Q9HD89
DQRQLLVEVERMECA

TLR4

596

O00206
FRMINEQQVEDITID

PTDSS1

21

P48651
CRFQEDQEMARDLVE

TCF25

296

Q9BQ70
ATLQRQEELETMCVQ

UBXN11

121

Q5T124
QEELETMCVQLQRQV

UBXN11

126

Q5T124
KVQFTVDCNVDIQDM

LRRC8C

286

Q8TDW0
EDQLVMVGQRVEFEC

MYBPC3

461

Q14896
ECAMETTEEQTRQER

NECAB1

151

Q8N987